Fedha

Hisa unazofuatilia
BNTX:NASDAQ
BioNTech SE
US$ 96.90
0.00%
(0.00) Siku 1
US$ 96.61
-0.30% (-0.29)
Kabla ya soko
Imefungwa: 2 Okt, 16:00:01 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya BNTX...
Mtaji wa soko
24.34B
Wastani wa kiasi cha mauzo
1.10M
Kiasi cha mauzo ya hisa
elfu 2.80
Juu kwa wiki 52
US$ 124.00
Chini kwa wiki 52
US$ 79.52
EPS
-US$ 7.55
Beta
1.22
Hisa za wawekezaji
251.20M
Idadi ya wafanyakazi
elfu 8
Mtaji wa soko
24.34B
Wastani wa kiasi cha mauzo
1.10M
Kiasi cha mauzo ya hisa
elfu 2.80
Juu kwa wiki 52
US$ 124.00
Chini kwa wiki 52
US$ 79.52
EPS
-US$ 7.55
Beta
1.22
Hisa za wawekezaji
251.20M
Idadi ya wafanyakazi
elfu 8
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
Kuhusu BioNTech SE
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 7.81
Lilianzishwa2008
Makao makuu-
Sekta-
Tovutibiontech.de
Ukadiriaji wa mchanganuzi
Kulingana na wachanganuzi 14 waliotoa ukadiriaji wa hisa kwa BNTX katika miezi 3 iliyopita
Imenunuliwa sana
Nunua
11
Shikilia
3
Uza
0
Utabiri wa miezi 12
Kulingana na wachanganuzi 14 wa Wall Street wanaotoa makadirio ya bei ya miezi 12 ya BNTX katika miezi 3 iliyopita.
Juu kabisa
Ya sasa US$ 96.90
US$ 140.00 (+44.48%)
Wastani
US$ 126.85 (+30.91%)
Chini kabisa
US$ 96.00 (-0.93%)
Mchanganuzi
Unaopendekezwa
Kitendo
Bei lengwa
Unaokadiriwa
Tarehe
Terence Flynn
Morgan Stanley
Buy
Reiterated
US$ 115.00
+18.7%
09/28/2026
Jeffrey Walch
Bernstein
Hold
Maintained
US$ 96.00
-0.9%
09/25/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
US$ 140.00
+44.5%
09/24/2026
John Newman
Canaccord Genuity
Buy
Maintained
US$ 136.00
+40.4%
09/23/2026
David Dai
UBS
Buy
Maintained
US$ 135.00
+39.3%
09/16/2026
Harry Gillis
Berenberg Bank
Buy
Maintained
US$ 140.00
+44.5%
09/15/2026
Akash Tewari
Jefferies
Buy
Maintained
US$ 138.00
+42.4%
09/15/2026
Evan Seigerman
BMO Capital
Hold
Maintained
US$ 105.00
+8.4%
09/14/2026
Asad Haider
Goldman Sachs
Buy
Maintained
US$ 127.00
+31.1%
09/14/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
US$ 122.00
+25.9%
09/14/2026
Geoff Meacham
Citi
Buy
Reiterated
US$ 125.00
+29%
08/31/2026
Emmanuel Papadakis
Deutsche Bank
Buy
Maintained
US$ 140.00
+44.5%
08/26/2026
Jessica Fye
J.P. Morgan
Hold
Maintained
-
-
08/19/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
US$ 130.00
+34.2%
08/05/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
US$ 140.00
+44.5%
08/05/2026
Unknown Analyst
Bernstein
Hold
Maintained
-
-
06/01/2026
Unknown Analyst
J.P. Morgan
Hold
Maintained
US$ 100.00
+3.2%
05/20/2026
Yaron Werber
TD Cowen
Hold
Maintained
US$ 94.00
-3%
05/05/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$ 130.00
+34.2%
04/27/2026
Asthika Goonewardene
Truist Financial
Buy
Maintained
US$ 155.00
+60%
03/13/2026
William Maughan
Clear Street
Buy
Reiterated
US$ 167.00
+72.3%
03/11/2026
Daina Graybosch
Leerink Partners
Hold
Downgraded
US$ 113.00
+16.6%
02/02/2026
Ripoti ya mwisho
4 Ago 2026
Kipindi cha Kifedha
Robo2 2026
Mapato kwa kila hisa dhidi ya makadirio (EUR)
-€ 2.22 / -€ 2.08
-6.80%hujafikia
Mapato dhidi ya makadirio (EUR)
105.60M / 155.71M
-32.18%hujafikia
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika EUR
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika EUR
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
1.52B
907.40M
118.10M
105.60M
Gharama ya bidhaa zilizouzwa
148.30M
302.80M
71.40M
97.00M
Gharama ya mapato
148.30M
302.80M
71.40M
97.00M
Gharama za utafiti na maendeleo
564.80M
505.40M
557.00M
477.10M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
148.50M
217.90M
150.80M
197.80M
Gharama ya uendeshaji
1.40B
907.20M
727.70M
860.40M
Jumla ya gharama za uendeshaji
1.55B
1.21B
799.10M
957.40M
Mapato ya uendeshaji
-33.00M
-302.60M
-681.00M
-851.80M
Mapato mengine yasiyo ya uendeshaji
96.80M
-173.80M
42.10M
23.80M
EBT ikijumuisha vipengee visivyo vya kawaida
24.70M
-227.40M
-568.10M
-858.70M
EBT bila kujumuisha vipengee visivyo vya kawaida
40.70M
-206.50M
-567.80M
-777.70M
Gharama ya kodi ya mapato
53.40M
77.60M
-36.20M
-37.90M
Kiwango cha kodi kinachotumika
216.19%
-34.12%
6.37%
4.41%
Gharama nyingine za uendeshaji
690.30M
183.90M
19.90M
185.50M
Mapato halisi
-28.70M
-305.00M
-531.90M
-820.80M
Kiwango cha faida halisi
-1.89%
-33.61%
-450.38%
-777.27%
Mapato kwa kila hisa
-0.12
-0.33
-1.95
-2.22
Mapato ya riba na uwekezaji
-
265.50M
61.70M
66.40M
Gharama ya riba
-2.60M
-
-4.00M
-3.50M
Jumla ya gharama halisi za riba
-2.60M
265.50M
57.70M
62.90M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
91.20M
-266.95M
-559.70M
-585.70M
Faida au hasara kutokana na uuzaji wa vipengee
-1.30M
elfu -800.00
elfu -100.00
elfu -900.00
Miamala ya wajuzi wa mambo
Data ya miamala ya watu wenye hisa hutolewa kwenye vyanzo vya washirika wengine. Pata maelezo zaidi
Mjuzi wa mambo
Nafasi
Aina
Tarehe
Hisa
Kiasi
Ukurasa wa 1
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho
Programu za Google